Rapid opioid detoxification during general anesthesia: A review of 20 patients

Anesthesiology

Volumn 91, Issue 6, 1999, Pages 1639-1647

  Gold, Carl G ^a   Cullen, David J ^b   Gonzales, Scott ^b   Houtmeyers, Deirdre ^b   Dwyer, Mary Jo ^b  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b NONE

Author keywords

Drug abuse rehabilitation; Human addictive disorders; Narcotic detoxification; opioid receptor blockade

Indexed keywords

METHADONE; NALMEFENE; NALOXONE; NALTREXONE; OPIATE;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; DRUG DETOXIFICATION; DRUG WITHDRAWAL; GENERAL ANESTHESIA; HEMODYNAMIC PARAMETERS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032760698     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199912000-00015     Document Type: Article

References (44)

1. O'Connor PG, Kosten TR: Management of opioid intoxification and withdrawal, Principles of Addiction Medicine. Edited by Miller N. Washington DC, American Society of Addiction Medicine, 1994, pp 1-6
2. Dole VP: A medical treatment for diacetylmorphine (heroin) addiction. JAMA 1965; 193:646-50
3. Bickel WK, Amass L, Higgins ST, Badger GJ, Esch RA: Effects of adding behavioral treatment to opioid detoxification with buprenorphine. J Consult Clin Psychol 1997; 65:803-10
4. Resnick RB, Kestenbaum RS, Washton A, Poole D: Naloxone-precipitated withdrawal: A method for rapid induction onto naltrexone. Clin Pharmacol Ther 1977; 21:409-13
5. O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ: Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Intern Med 1997; 127:526-30
6. Mattick RP, Hall W: Are detoxification programmes effective? Lancet 1996; 347:97-100
7. Gold ML, Sorensen JL, McCanlies N, Trier M, Dlugosch G: Tapering from methadone maintenance: Attitudes of clients and staff. J Subst Abuse Treat 1988; 5:37-44
8. Azatian A, Papiasvilli A, Joseph H: A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR. J Addict Dis 1994; 13:35-52
9. Simon DL: Rapid opioid detoxification using opioid antagonists: history, theory and the state of the art. J Addict Dis 1997; 16:103-22
10. Seoane A, Carrasco G, Cabre L, Puiggros A, Hernandez E, Alvarez M, Costa J, Molina R, Sobrepere G. Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry 1997; 171:340-5
11. Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ: Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological, and biochemical correlates. J Neurosci 1990; 10:2308-17
12. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC, American Psychiatric Association, 1994, pp 175-82
13. Catafau AM, Etcheberrigaray A, Perez de los Cobos J, Estorch M, Guardia J, Flotats A, Berna L, Mari C, Casas M, Cario I: Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexone challenge during detoxification. J Nucl Med 1999; 40:19-24
14. Tonneson AS: Crystalloids and colloids, Anesthesia, 4th Edition. Edited by Miller RD. New York, Churchill Livingstone, 1994, p 1611
15. Prough DS, Mathru M: Acid-base, fluids, and electrolytes, Clinical Anesthesia, 3rd edition. Edited by Barash PG, Cullen BF, Stoelting RK. Philadelphia, Lippincott-Raven Publishers, 1997, p 165
16. Fultz JM, Senay EC: Guidelines for the management of hospitalized narcotics addicts. Ann Intern Med 1975; 82:815-8
17. Gold MS, Redmond DE Jr, Kleber HD: Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. Am J Psychiatry 1979, 136:100-2
18. Gold MS: Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine. Psychiatr Clin North Am 1993; 16:61-73
19. Lin SK, Strang J, Su LW, Tsai CJ, Hu WH: Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal. Drug Alcohol Depend 1997; 48:127-33
20. Buchanan KD: Effects of sandostatin on neuroendocrine tumours of the gastrointestinal system. Recent Results Cancer Res 1993; 129:45-55
21. Physician's Desk Reference, 51st edition. Montvale, NJ, Medical Economics Company, 1997, pp 2421-3
22. Tanaka GY: Hypertensive reaction to naloxone. JAMA 1974; 228:25-6
23. Andree RA: Sudden death following naloxone administration. Anesth Analg 1980; 59:782-4
24. Johnson C, Mayer P, Grosz D: Pulmonary edema following naloxone administration in a healthy orthopedic patient. J Clin Anesth 1995; 7:356-7
25. Kaplan JL, Marx JA: Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: a pilot study. Ann Emerg Med 1993; 22:187-90
26. Gal TJ, DiFazio CA: Prolonged antagonism of opioid action with intravenous nalmefene in man. ANESTHESIOLOGY 1986; 64:175-80
27. Dixon R. Howes J, Gentile J, Hsu HB, Hsiao J, Garg D, Weidler D, Meyer M, Turtle R: Nalmefene: Intravenous safety and kinetics of a new opioid antagonist. Clin Pharmacol Ther 1986; 39:49-53
28. San L, Torrens M, Tato J, Castillo C, de la Torre R, Arranz B: Monitoring patterns of substance use in drug-dependent patients. J Subst Abuse Treat 1998; 15:425-30
29. Presslich O, Loimer N, Lenz K, Schmid R: Opiate detoxification under general anesthesia by large doses of naloxone. J Toxicol Clin Toxicol 1989; 27:263-70
30. Loimer N, Schmid R, Lenz K, Presslich O, Grunberger J: Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. Br J Psychiatry 1990; 157:748-52
31. Legarda JJ, Gossop M: A 24-h inpatient detoxification treatment for heroin addicts: A preliminary investigation. Drug Alcohol Depend 1994; 35:91-3
32. O'Connor PG, Kosten TR: Rapid and ultrarapid opioid detoxification techniques. JAMA 1998; 279:229-34
33. Gerra G, Fertonani G, Tagliavini P, Zaimovic A, Delsignore R, Maestri D, Avanzini P, Caccavari R, Brambilla F: Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge. Psychiatry Res 1995; 58:153-60
34. Langer G, Karazman R, Neumark J, Saletu B, Schonbeck G, Grunberger J, Dittrich R, Petricek W, Hoffmann P, Linzmayer L, Anderer P, Steinberger K: Isoflurane narcotherapy in depressive patients refractory to conventional antidepressant drug treatment. A double-blind comparison with electroconvulsive treatment. Neuropsychobiology 1995; 31:182-94
35. Kienbaum P, Thurauf N, Michel MC, Scherbaum N, Gastpar M, Peters J: Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. ANESTHESIOLOGY 1998; 88:1154-61
36. Hoffman WE, Berkowitz R, McDonald T, Hass F: Ultra-rapid opioid detoxification increases spontaneous ventilation. J Clin Anesth 1998; 10:372-6
37. Miyamoto Y, Takemori AE: Sites of action of naloxone in precipitating withdrawal jumping in morphine-dependent mice: Investigations by the ED50 value and CNS content of naloxone. Drug Alcohol Depend 1993; 32:163-7
38. Shook J, Kazmierski W, Hruby V, Burks T: Precipitation of spinally mediated withdrawal signs by intrathecal administration of naloxone and the mu-receptor antagonist CTP in morphine-dependent mice. NIDA Res Monogr 1988; 81:143-8
39. Vining E, Kosten TR, Kleber HD: Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 1988; 83:567-75
40. O'Connor PG, Waugh ME, Carroll KM, Rounsaville BJ, Diagkogiannis IA, Schottenfeld RS: Primary care-based ambulatory opioid detoxification: The results of a clinical trial. J Gen Intern Med 1995; 10:255-60
41. Physicians Desk Reference, 51st edition. Montvale, NJ, Medical Economics Company, 1997, p 959
42. Stephenson J: Experts debate merits of 1-day opiate detoxification under anesthesia. JAMA 1997; 277:363-4
43. Simon DL: The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction. Conn Med 1996; 60:683-5
44. Bradley CJ, French MT, Rachal JV: Financing and cost of standard and enhanced methadone treatment. J Subst Abuse Treat 1994; 11:433-42